Prognosis

Delhi, India Founded: 2002 • Age: 24 yrs Acquired By MedGenome
Diagnostic services in cardiology, radiology, pathology, and imaging are offered.

About Prognosis

Prognosis is a Healthcare company based in Delhi (India) founded in 2002 by Deepak Sadwani and Smita Sadwani, and was acquired by MedGenome in May 2023. Diagnostic services in cardiology, radiology, pathology, and imaging are offered. The company has 74 employees. Its focus areas include Clinical Laboratories and Diversified. Its legal entity is Prognosis Laboratories.

Company details

Prognosis was established in 2002 as a standalone diagnostic centre in Delhi, India. Operations focus on healthcare diagnostics within the medical sector. A range of services is provided, encompassing cardiology consultations, radiology examinations, pathology testing, and imaging modalities such as digital X-ray and ultrasonography. The centre is directed by co-founders Deepak Sadwani and Smita Sadwani.

  • Headquarters Delhi, India
  • Employees 74
  • Founders Deepak Sadwani, Smita Sadwani
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website prlworld.com
  • Social LinkedIn Facebook
  • Acquired by MedGenome (May 2023)
  • Legal Name Prognosis Laboratories
Operational Areas
Key Metrics
  • Annual Revenue
    $1.72 M (USD)
    as on Mar 31, 2024
  • Net Profit
    -$613.41 K (USD)
    as on Mar 31, 2024
  • EBITDA
    -$38.66 K (USD)
    as on Mar 31, 2024
  • Investors
  • Employee Count
    74
  • Acquired by
    MedGenome

    (May 2023)

Investors in Prognosis

Prognosis has secured backing from 1 investor. Prominent investors backing the company include MedGenome.

All
InvestorDescriptionFounded YearDomainLocation
DNA sequencing, bioinformatics, and multiomics services are provided.
2013medgenome.comBengaluru, India
Premium access

Investor details for Prognosis

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Prognosis

2 people are tracked at Prognosis (2 in leadership); the tracked headcount is 74.

NameRoleGroup
Deepak Sadwani
Co-Founder & DirectorLeadership
Smita Sadwani
Co-Founder & DirectorLeadership
Premium access

Complete people profiles for Prognosis

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Prognosis

2 dated milestones of Prognosis across 21 years, from founding to its latest funding, stage changes and deals.

  1. Founded Prognosis is founded.
  2. Exit Acquired by MedGenome.

Web traffic of Prognosis

The website of Prognosis (prlworld.com) receives about 1.9K visits a month.

  • Monthly visits
    1.9K

    ▼ 67% vs previous month

Similar websites

Websites whose visitors overlap most with Prognosis. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
ceedeediagnostics.net
ceedeediagnostics.net
100%
–
sanjeevanipathlabs.com
95%
#11,852,525View details

Top companies in Diagnostics Laboratories

3 companies that operate in the same segment as Prognosis (Diagnostics Laboratories) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Diagnostic testing centers for pathology and health screenings are operated.
1996Mumbai, Maharashtra, IndiaUSD 63.59 MUSD 90.17 M1,979
Chain of pathology and radiology labs
1949Gurugram, Haryana, IndiaUSD 13.9 MUSD 294.49 M5,310
Home-based diagnostic tests are booked via an online platform.
2018Noida, Uttar Pradesh, IndiaUSD 116.42 MUSD 52.45 M2,334
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Prognosis

Premium access

Complete news archive for Prognosis

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Prognosis

Prognosis was founded in 2002.

Prognosis is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.

Prognosis has 74 employees.

Annual revenue of Prognosis is $1.72M as on Mar 31, 2024.

Prognosis was established in 2002 as a standalone diagnostic centre in Delhi, India. Operations focus on healthcare diagnostics within the medical sector. A range of services is provided, encompassing cardiology consultations, radiology examinations, pathology testing, and imaging modalities such as digital X-ray and ultrasonography. The centre is directed by co-founders Deepak Sadwani and Smita Sadwani.

Prognosis has 1 investor. Key investors include MedGenome.

Prognosis operates through Prognosis Laboratories.

Yes. Prognosis was acquired by MedGenome in May 2023.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available